A wave of illnesses and deaths in the U.S. linked to vaping products may dampen demand for soon-to-be-legal cannabis vapes in Canada later this year, industry watchers say.
An ongoing vaping probe south of the border — where as many as five people have died and hundreds more have fallen ill — may slow sales growth in what has been one of the fastest-growing categories in the industry, said Jennifer Lee, Deloitte Canada’s Cannabis national leader.
"It's going to create some hesitation in the market," she said in an interview. However, new users are more likely to be deterred than smokers who are looking to shift to reduced-risk products, Lee added.
A growing number of health and regulatory authorities in recent days have urged consumers to stop vaping until it is clear what the root cause is.
Read more at fcc-fac.ca
